|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 927.89 USD | +13.33% |
|
+15.26% | +20.21% |
| 10-31 | US Equity Markets End Lower After Sell-Off in Technology Stocks | MT |
| 10-30 | Regeneron Pharmaceuticals, Inc. announces Quarterly dividend, payable on December 03, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | +13.33% | +15.26% | +20.21% | +42.36% | +45.00% | 92.65B |  | | |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
